Gianluca Svegliati-Baroni

10PUBLICATIONS
80CO-AUTHORS
Political economy and social changeHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 04, 2025
Diagnosed Patients With Chronic Hepatitis B and Delta Virus in Italy in 2024: An Estimation From a National Real-World Database.

Alessandro Loglio, Ivan Gardini, Massimiliano Conforti

|Jan 08, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular Carcinoma.

Edoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres

|Jul 03, 2024
Microwave ablation followed by cTACE in 5-cm HCC lesions: does a single-session approach affect liver function?

Chiara Floridi, Laura Maria Cacioppa, Nicolò Rossini

|Sep 27, 2023
Predictors of non-transplantable recurrence in hepatocellular carcinoma patients treated with frontline liver resection.

Filippo Pelizzaro, Franco Trevisani, Vittorio Simeon

|Dec 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.

Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani

|Nov 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an update.

Francesca Garuti, Andrea Neri, Francesca Avanzato

Pageof 2